OTCM
IVBT
Market cap4kUSD
Jul 09, Last price
0.00USD
1D
0.00%
IPO
-99.99%
Name
Innovation1 Biotech Inc
Chart & Performance
Profile
Gridiron BioNutrients, Inc. develops, markets, and sells cannabidiol products. The company offers capsules, oil, gummies, concentrates, water, beverages, hemp tinctures, and salves. It sells its products under the Gridiron BioNutrients and Gridiron MVP names through an online platform. The company was founded in 2014 and is based in Scottsdale, Arizona.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑08 | 2022‑08 | 2021‑08 | 2020‑08 | 2019‑08 | 2018‑08 | 2017‑08 | 2016‑08 | 2015‑08 | |
Income | |||||||||
Revenues | |||||||||
Cost of revenue | 763 | 5,250 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | (763) | (5,250) | |||||||
NOPBT Margin | |||||||||
Operating Taxes | 2,414 | ||||||||
Tax Rate | |||||||||
NOPAT | (763) | (7,663) | |||||||
Net income | (5,988) -85.35% | (40,878) -5,136.94% | |||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | 4,000 | ||||||||
BB yield | |||||||||
Debt | |||||||||
Debt current | 10 | 209 | |||||||
Long-term debt | 219 | 796 | |||||||
Deferred revenue | |||||||||
Other long-term liabilities | 11,000 | ||||||||
Net debt | 179 | 849 | |||||||
Cash flow | |||||||||
Cash from operating activities | (620) | (3,128) | |||||||
CAPEX | (5) | (3) | |||||||
Cash from investing activities | (853) | ||||||||
Cash from financing activities | 514 | 4,000 | |||||||
FCF | (26,384) | 21,091 | |||||||
Balance | |||||||||
Cash | 50 | 156 | |||||||
Long term investments | |||||||||
Excess cash | 50 | 156 | |||||||
Stockholders' equity | (58,602) | (44,523) | |||||||
Invested Capital | 55,401 | 58,883 | |||||||
ROIC | |||||||||
ROCE | 23.85% | ||||||||
EV | |||||||||
Common stock shares outstanding | 20,184 | 15,226 | |||||||
Price | 0.85 | ||||||||
Market cap | 17,157 | ||||||||
EV | 17,344 | ||||||||
EBITDA | (711) | (5,111) | |||||||
EV/EBITDA | |||||||||
Interest | 252 | 6 | |||||||
Interest/NOPBT |